S111* (p.Ser111Ter) variant of PON1 (Serum paraoxonase/arylesterase 1)
S111* (p.Ser111Ter) in PON1 (Serum paraoxonase/arylesterase 1) is a protein-truncating change. Clinical records from UniProt describe it as variant assessed as somatic; high impact. The available variant effect predictions contribute to a CATVariant prioritization score of 0.65 / 1. The record also includes population frequency data and structural context.
S111* (p.Ser111Ter) variant details
- p.Ser111Ter
- NCI-TCGA Cosmic COSV5593
- Variant assessed as somatic; high impact.
- Stop Gained
- Variant Prioritization Score for Impact Estimate 0.652
- CADD 42.00
- UniProt: Variant assessed as somatic; high impact.
- Population evidence available
- Structural context available